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Abstract
Background: Factors associated with the development of atrial fi brillation (AF) in general 
population have been described, but it is still unknown whether the same risk factors apply 
to heart failure (HF) patients. The aim of this study was to identify clinical factors related to 
various forms of AF in HF patients.
Methods: The clinical and echocardiographic characteristics were assessed in 155 HF pa-
tients: 50 with sinus rhythm, 52 with non-permanent AF, and 53 with permanent AF. 
Results: Multivariate logistic regression analysis showed that the increase in the NYHA 
class was an independent risk factor for both forms of AF. The occurrence of permanent AF in 
comparison to sinus rhythm group was independently associated with hs-C-reactive protein 
(CRP) elevation above 1 mg/dL (OR 1.87, 95% CI 1.05–3.35), left atrial dimension above 
4 cm (OR 3.78, 95% CI 1.29–11.06) and tricuspid maximal pressure gradient elevation above 
35 mm Hg (OR 5.01, 95% CI 1.38–18.27). The presence of coronary disease was independently 
associated with less frequent occurrence of permanent AF in comparison to sinus rhythm group 
(OR 0.21, 95% CI 0.06–0.67). 
Conclusions: More advanced congestive HF was associated with presence of both types of AF. 
Non-ischemic etiology of HF and elevated CRP are independently associated with permanent 
AF compared to sinus rhythm. Left ventricular diastolic dysfunction indicators (increased 
tricuspid maximal pressure gradient and left artial dimension) are independently associated 
with permanent AF. (Cardiol J 2013; 20, 4: 364–369) 
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Introduction
The advent of modern treatments in cardiology 
and the resulting survival benefi t in industrialized 
countries have considerably increased the size of 
the population of patients suffering from congestive 
heart failure (CHF), estimated at over 15 million 
in the European Union [1].
Coronary artery disease (CAD), hypertension 
and tachyarrhythmia, usually in the form of atrial 
fi brillation (AF), are believed to be the most com-
mon causative factors of myocardial dysfunction 
[2–4]. The development of AF in CHF patients 
further exacerbates the signs and symptoms of 
HF, increases the risk of thromboembolic events 
and adversely affects the long-term prognosis [3].
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While factors associated with the development 
of AF in the general population of patients have 
been identifi ed [5], it remains unclear whether the 
same risk factors apply to the population of patients 
suffering from CHF. The known causes of AF in 
patients with CHF include rapidly progressive 
conditions, such as hyperthyroidism, electrolyte 
imbalance, acute myocardial ischemia, alcohol 
abuse and heart surgery [3]. Maisel and Stevenson 
[6] reported an increased incidence of AF with 
increasing severity of CHF, as assessed using the 
New York Heart Association (NYHA) functional 
classifi cation. It has not been established whether 
there is an independent association between AF 
and the increasing severity of CHF assessed using 
the NYHA classifi cation or between AF and CHF 
assessed by echocardiographic parameters. Studies 
in patients without HF describe an association of 
AF with markers of infl ammation [7, 8]. In the case 
of AF in patients with CHF this association has not 
yet been elucidated [9].
Identifi cation of factors associated with the de-
velopment and persistence of cardiac arrhythmias 
is of important prognostic signifi cance and may play 
a role in therapy if these factors can be modifi ed.
The aim of the study was to identify factors 
associated with various forms of AF in the popu-
lation of patients with CHF.
Methods
This was a cross-sectional study investigating 
a population of patients with CHF. The study was 
approved by the local ethics committee. All the pa-
tients met the European Society of Cardiology (ESC) 
diagnostic criteria of CHF [3]. Patients with acute 
(up to 3 months duration) and chronic infl ammatory 
diseases, hyperthyroidism, hemodynamically signifi -
cant valvular disease, NYHA class IV CHF, or cancer 
were excluded from the study. The study population 
consisted of patients referred to the Cardiology 
Clinic by 41 general practitioners over a period of 
15 months. Consecutive patients were assigned 
to one of the following 3 groups: the sinus rhythm 
(SR) group, the non-permanent AF (npAF) group 
(3 patients with paroxysmal and 49 with persistent 
AF) or to the permanent AF (pAF) group. The ESC 
classifi cation of AF was followed [5].
We assessed the baseline demographic and 
clinical characteristics of the study patients. The 
severity of CHF was established in accordance with 
the NYHA functional classifi cation. The diagnosis 
of hypertension was based on the history or mea-
surements of blood pressure values in accordance 
with the ESH/ESC guidelines [10]. The diagnosis 
of CAD was established in patients with a history 
of ST-elevation myocardial infarction or based on an 
angiographically confi rmed signifi cant narrowing 
of an epicardial coronary artery. The diagnoses of 
diabetes mellitus and metabolic syndrome were 
established in accordance with the International 
Diabetes Federation criteria [11]. Conduction ab-
normalities in the form of bundle branch blocks or 
atrioventricular block were diagnosed by ECG and/
/or based on a history of a pacemaker implantation. 
Laboratory and echocardiographic assessments 
were ordered during the fi rst study visit. The pa-
tients underwent transthoracic echocardiography 
performed with GE Vingmed System FIVE using 
the standard 2.5–5.0 MHz probe. The methods of 
the study have been reported previously [9].
The results are presented as frequency values 
or calculated mean values for the analyzed groups 
of patients.
Preliminary statistical analysis of the study 
parameters allowed us to determine whether the 
percentage of patients within a particular class of 
a given parameter is independent of the group of 
patients classifi ed on the basis of the presence 
and type of AF and whether the mean values of 
a given parameter in individual groups are similar 
or signifi cantly different.
The distribution of hs-C-reactive protein 
(CRP) levels was not normal, hence the natural 
logarithm of the hs-CRP levels (ln CRP) was used 
for further analyses.
The mean values in the groups were compared 
using parametric tests (the t-Student or Cochrane-
-Cox tests) or the non-parametric U Mann-Whitney 
test.
Some continuous variables were transformed 
into dichotomized variables using their upper limits 
of normal as threshold values. Patients with left 
ventricular ejection fraction (LVEF) values below 
45% made up Class 1, while the remaining patients 
made up Class 2. Patients with the maximum pres-
sure gradient across the tricuspid valve (tMxPG) 
values below 35 mm Hg made up Class 1, while 
the remaining patients made up Class 2. The rema-
ining variables were categorized as follows: NYHA 
functional classes were categorized in 3 classes; 
hs-CRP levels in 3 classes (≤ 1.00 mg/L, 1.01–
–3.00 mg/L and > 3.00 mg/L) [12, 13]; left atrial (LA) 
dimension in 3 classes (≤ 4 cm, 4.01–5.00 cm and 
> 5.00 cm) [9].
Univariate logistic regression analysis was 
used to determine which of the analyzed variables 
were signifi cantly associated with the particular 
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types of AF. The variables for which the signifi can-
ce level was below 0.10 were used as the baseline 
variables for multivariate logistic regression ana-
lysis. An optimal subset of variables was identifi ed. 
The odds ratio was estimated from the following 
formula: OR = ORAxB = S(X = A)/S(X = B) = P(Y 
= 1|X = A)/P(Y = 1|X = B), for A > B, where A and B 
referred to classes of the independent factor X.
A signifi cance level of 0.05 was adopted to 
verify the statistical hypotheses. The statistical 
analysis was performed using Statistica 6.0 PL.
Results
Baseline characteristics of the 3 study groups 
and the results of the statistical tests to verify 
the significant differences between the groups 
are presented in Table 1. Although the patients 
in the npAF group were older than the patients 
in the remaining 2 groups, the difference was 
statistically significant only vs. the SR group 
(p = 0.038). CAD was signifi cantly more common 
in the SR and the npAF groups than in the pAF 
group (p = 0.03 and p = 0.017, respectively). 
The highest percentage of patients with diabetes 
mellitus was identifi ed in the SR group (p < 0.001 
for both comparisons). This percentage decreased 
with increasing severity of AF. The prevalence of 
haemodynamically signifi cant mitral insuffi ciency 
and peripheral edema was signifi cantly higher in 
the pAF group vs. the SR group (p = 0.005 and 
p = 0.045, respectively). The prevalence of NYHA 
class III HF was signifi cantly higher in the npAF 
and pAF groups than in the SR group (p = 0.06 
and p < 0.001, respectively). Table 1 presents also 
the details of the pharmacological treatment in the 
study groups. The differences in pharmacotherapy 
resulted from the underlying cause and severity of 
CHF and from the presence of AF. The exception 
was the treatment with angiotensin-converting 
enzyme inhibitors, which was less common in the 
npAF group than in the pAF group as a result of the 
more frequent use of angiotensin receptor blockers 
in the pAF group (6 patients).
The results of laboratory and echocardiograp-
hic assessments in the study groups are summari-
Table 1. Patients characteristics.
Analyzed parameters Patient groups by type of arrhythmia P**
SR Non-permanent AF Permanent AF 
N = 53 N = 52 P* N = 50 P*
Age 72.2 ± 9.2 76.2 ± 10.0 0.038 74.5 ± 9.9 NS NS
Male 37 (69.8%) 34 (65.4%) NS 30 (60.0%) NS NS
Hypertension 40 (75.5%) 39 (75.0%) NS 38 (76.0%) NS NS
Diabetes mellitus 48 (90.6%) 22 (42.3%) < 0.001 11 (22.0%) < 0.001 0.033
Coronary artery disease 34 (64.1%) 30 (57.7%) NS 17 (34.0%) 0.003 0.017
Dilated cardiomyopathy 3 (5.7%) 3 (5.8%) NS 6 (12.0%) NS NS
Mitral insufficiency 4 (7.5%) 7 (13.5%) NS 15 (30.0%) 0.005 NS
Systolic heart failure 32 (60.4%) 37 (71.2%) NS 36 (72.0%) NS NS
NYHA class III 9 (17.0%) 22 (42.3%) 0.006 28 (56.0%) < 0.001 NS
Peripheral edema 20 (37.7%) 26 (50.0%) NS 29 (58.0%) 0.045 NS
Conduction abnormalities 24 (50.9%) 19 (36.5%) NS 22 (44.0%) NS NS
BMI [kg/m2] 28.6 ± 5.1 29.4 ± 5.0 NS 29.4 ± 6.5 NS NS
Metabolic syndrome 24 (45.3%) 23 (44.2%) NS 15 (30.0%) NS NS
ACEI 50 (94.3%) 50 (96.2%) NS 44 (88.0%) NS 0.014
ARB 0 0 6
Beta-blocker 44 (83.0%) 46 (88.5%) NS 45 (90.0%) NS NS
Statin 46 (86.8%) 45 (86.5%) NS 28 (56.0%) 0.001 0.001
Spironolactone 34 (64.2%) 38 (73.1%) NS 40 (80.0%) NS NS
Diuretics 35 (66.0%) 36 (69.2%) NS 44 (88.0%) 0.010 0.022
Aspirin 45 (84.9%) 44 (84.6%) NS 26 (52.0%) 0.001 0.001
Acenocoumarol 4 (7.5%) 24 (46.2%) < 0.001 37 (74.0%) < 0.001 0.005
*vs. SR, **non-permanent AF vs. permanent AF; SR — sinus rhythm; AF —  atrial fibrillation; BMI — body mass index; ACEI  — angiotensin-
-converting enzyme inhibitors; ARB — angiotensin receptor blockers
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zed in Table 2. The mean hs-CRP levels (ln CRP) 
were higher in the npAF and pAF groups than in 
the SR group (p = 0.052 and p < 0.001, respec-
tively). The pAF group was also characteri-
zed by a significantly higher fibrinogen levels 
compared to the other 2 groups (p = 0.021 and 
p = 0.007, respectively) and by a significantly 
higher serum creatinine levels compared to the 
SR group (p = 0.010). Sodium levels were signi-
fi cantly higher (p = 0.025) and total cholesterol 
signifi cantly lower (p = 0.036) in the npAF group, 
compared to the SR group. There were no signi-
fi cant differences in LVEF between the npAF or 
pAF groups and the SR group. LA dimension was 
signifi cantly higher in the pAF group (p < 0.001 and 
p < 0.001, respectively) as was tMxPG (p < 0.001 
and p < 0.001, respectively). Right ventricular (RV) 
dimension was higher in the pAF group compared 
to the npAF group (p = 0.004).
The parameters showing a statistically signifi -
cant association with the presence of arrhythmia on 
univariate logistic regression analysis were: diabe-
tes mellitus, CAD, NYHA class of CHF, the levels 
of hs-CRP, fi brinogen, serum creatinine and sodium, 
and LA dimension, RV dimension and tMxPG. The 
parameters for which the signifi cance level did not 
exceed 0.10 were the baseline parameters for multi-
variate logistic regression analysis, which allowed us 
to identify an optimal subset of factors of which the 
most important ones may be treated as variables in-
dependently associated with a particular type of AF.
The fi nal results of the multivariate logistic 
regression analysis for the above types of AF are 
summarized in Table 3.
The optimal subset of parameters describing 
the likelihood of npAF included: NYHA class of 
CHF, hs-CRP levels and LA dimension, treated 
as the classifi ed variables. The increase in the 
severity of CHF, as assessed by the NYHA fun-
ctional class, was the only variable independently 
associated with npAF.
In addition, the optimal subset of independent 
variables described by the likelihood of pAF also 
included: confi rmed CAD and elevated tMxPG. The 
multivariate logistic regression analysis revealed 
that elevated hs-CRP, NYHA class increase, LA 
enlargement and tMxPG increase above 35 mm Hg 
were independently associated with pAF, whereas 
CAD was independently associated with reduced 
odds of pAF after multivariable adjustment.
Table 2. Comparison of laboratory and echocardiographic parameters between the study groups.
Analyzed parameters SR Non-permanent AF Permanent AF P**
N = 53 N = 52 P* N = 50 P*
hs-CRP [mg/L] 4.27 ± 11.2 8.81 ± 27.3 8.84 ± 11.6
ln hs-CRP 0.67 ± 1.11 1.13 ± 1.27 0.052 1.56 ± 1.20 < 0.001 NS
Fibrinogen [mg/dL] 361.4 ± 79.6 355.5 ± 65.6 NS 398.0 ± 87.2 0.021 0.007
Hemoglobin [g/dL] 14.0 ± 1.5 13.4 ± 1.7 NS 13.9 ± 1.6 NS NS
MCV [µm3] 91.4 ± 4.0 91.6 ± 5.6 NS 91.2 ± 6.1 NS NS
Platelets [× 103/mL] 194.5 ± 55.8 182.3 ± 52.1 NS 186.1 ± 63.5 NS NS
WBC (× 103/mL) 7.6 ± 2.0 7.4 ± 2.0 NS 7.3 ± 2.1 NS NS
Serum creatinine [mg/dL] 0.99 ± 0.39 1.10 ± 0.57 NS 1.12 ± 0.30 0.010 NS
Na+ [mmol/L] 139.5 ± 2.8 140.7 ± 3.4 0.025 140.3 ± 3.1 NS NS
K+ [mmol/L] 4.33 ± 0.41 4.48 ± 0.40 NS 4.39 ± 0.47 NS NS
Glucose [mg/dL] 106.1 ± 25.1 109.4 ± 33.9 NS 103.7 ± 32.8 NS NS
Total cholesterol [mg/dL] 177.6 ± 45.2 158.5 ± 34.7 0.036 163.9 ± 47.3 NS NS
Triglycerides [mg/dL] 137.6±82.3 119.7±70.1 NS 121.8±70.1 NS NS
HDL-cholesterol [mg/dL] 54.2 ± 14.7 50.7 ± 16.0 NS 51.9 ± 16.5 NS NS
LDL-cholesterol [mg/dL] 95.9 ± 43.0 83.8 ± 32.6 NS 87.7 ± 40.0 NS NS
LA [cm] 4.40 ± 0.58 4.56 ± 0.81 NS 5.20 ± 0.77 < 0.001 < 0.001
LV [cm] 5.90 ± 1.03 5.86 ± 0.98 NS 5.85 ± 1.08 NS NS
LVEF [%] 45.7 ± 13.8 42.1 ± 12.7 NS 43.7 ± 14.1 NS NS
RV [cm] 2.62 ± 0.40 2.49 ± 0.52 NS 2.80 ± 0.58 NS 0.004
tMxPG [mm Hg] 16.9 ± 17.7 18.6 ± 15.0 NS 36.2 ± 17.4 < 0.001 < 0.001
*vs. SR, **non-permanent AF vs. permanent AF; SR — sinus rhythm; AF — atrial fibrillation; CRP — C-reactive protein; MCV — mean 
corpuscular volume; LA — left atrium; LV — left ventricle; RV — right ventricle; LVEF — left ventricular ejection fraction; tMxPG — tricu-
spid maximal pressure gradient
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Factors signifi cantly and independently asso-
ciated with pAF, when the failure was npAF, turned 
out to be: increased LA dimension and elevated 
tMxPG above 35 mm Hg.
Discussion
Although the CHF patients in both AF groups 
were older than those in the SR group, the diffe-
rence was not independently associated with AF. 
A similar fi nding of the higher prevalence of AF 
among older patients was reported in the Euro-
Heart Failure Survey [14]. We did not identify any 
association between the arrhythmia and hyperten-
sion, or increasing obesity, as assessed by body 
mass index, which are factors associated with AF 
in the general population [5]. The analysis of a large 
European population of patients with HF conducted 
by Rivero-Ayerza et al. [14] also demonstrated no 
signifi cant differences in the prevalence of obesity 
and hypertension between patients with AF and 
patients with SR, which confirms our findings 
obtained in a relatively small randomly selected 
group of patients.
Diabetes mellitus and CAD are considered 
to be the factors that are associated with the 
development of AF in general population of pa-
tients [5]. In our group of patients with HF the 
prevalence of diabetes mellitus and CAD were 
the highest in the SR group and decreased with 
the severity of the arrhythmia. In a multivariate 
logistic regression analysis, the diagnosis of CAD 
was associated with about a 5-fold decrease in 
odds ratio for the development of pAF vs. the SR 
group. In this context, it is notable that Lee et 
al. [15], in the Framingham population with CHF, 
showed a significantly higher prevalence of AF in 
patients in whom CHF resulted from non-corona-
ry causes. Similarly, Rivero-Ayerza et al. [14], in 
a population of patients with CHF, observed that 
CAD and diabetes mellitus were significantly less 
prevalent in patients with CHF and AF compared 
to the population of CHF patients with SR. Our 
study confirmed these findings and showed an 
independent association between CAD and the 
less common occurrence of pAF.
Univariate logistic regression analysis shows 
that both npAF and pAF are signifi cantly associated 
Table 3. Multivariable analysis; optimal subsets of independent variables.
Independent 
variables X 
Factors (number 
of classes)
Regression 
coefficients
P OR** 95% CI*** 
One class 
change
Range 
changes
One class 
change
Range 
changes
III A – Y*:  AF (1 — non-permanent AF; 0 — sinus rhythm)
Intercept –2.701
NYHA (3 classes) 1.243 0.001 3.47 12.01 1.70–7.08 2.88–50.15
hs-CRP (3 classes) 0.123 NS 1.14 1.45 0.74–1.72 0.41–5.12
LA (3 classes) 0.297 NS 1.35 1.81 0.68–2.66 0.46–7.09
III B – Y*: AF (1 — permanent AF; 0 — sinus rhythm)
Intercept –7.747
CAD –1.582 0.008 0.21 0.06–0.67
NYHA (3 classes) 1.508 0.004 4.52 20.40 1.61–12.70 2.57–161.38
hs-CRP (3 classes) 0.755 0.033 1.87 6.56 1.05–3.35 1.14–37.68
LA (3 classes) 1.484 0.014 3.78 14.28 1.29–11.06 1.67–122.36
tMxPG 1.719 0.013 5.01 1.38–18.27
III C – Y*: AF (1 — permanent AF; 0 — non-permanent AF)
Intercept –2.52
CAD –0.865 0.061 0.42 0.17–1.05
hs-CRP (3 classes) 0.491 NS 1.63 4.37 0.97–2.76 0.91–21.08
LA (3 classes) 1.135 0.003 2.9 8.41 1.42–5.92 2.02–35.03
tMxPG 1.411 0.004 4.1 1.54–10.89
*Dichotomized variable Y describing the type of atrial fibrillation (1 — success; 0 — failure); **Odds ratio (OR) for the change in the value 
of the independent variable; ***95% confidence interval for OR; AF — atrial fibrillation; CAD — coronary artery disease; tMxPG — tricuspid 
maximal pressure gradient; LA — left atrium
OR = ORAxB = P(Y=1|X=A)/P(Y=1|X=B), A>B –> number of classes of variable X
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with elevated hs-CRP levels. In multivariate ana-
lysis, this association has only been confi rmed for 
pAF. The higher was its value, the higher was the 
likelihood of developing AF. Chung et al. [8] were the 
fi rst who reported the association between AF and 
increasing hs-CRP levels, relative to the severity 
of AF in patients without HF. In the case of patients 
with CHF, this association remains unclear. Shah et 
al. [16] demonstrated an association between serum 
hs-CRP and increasing LV end-diastolic pressure. 
Smith et al. [17] showed that the occurrence of AF 
was independently associated with elevated MR-
-proANP and hs-CRP. These fi ndings suggest that 
hs-CRP elevation may be associated with increa-
sed vascular wall tension, which may explain its 
independent association with LA enlargement and 
hypertension in the group of patients with CHF [9].
We also observed that the prevalence of AF 
increases with the severity of CHF as assessed 
using the NYHA functional classifi cation, which 
may result from the increasing predisposition to 
developing AF with increasing fi lling pressures in 
the atria and their enlargement [5, 6]. We confi r-
med this association and showed its independent 
nature. An increase of one NYHA class resulted in 
an almost 3.5-fold increase in odds ratio for deve-
loping npAF and a 4.5-fold increase in odds ratio 
for developing pAF.
The LA enlargement and the elevated tMxPG 
values we observed were independently associa-
ted with pAF. The higher were these parameters, 
the higher was the likelihood of developing this 
arrhythmia. An association between both of these 
parameters has been shown in the course of CHF. 
Berkowitz et al. [18] observed that the severity 
of pulmonary hypertension increased with the 
severity of LV diastolic dysfunction. It also has 
been shown that LA volume was depended on the 
severity of LV diastolic dysfunction [19]. These 
fi ndings suggest that the disordered LV diastole 
signifi cantly affects both these parameters. LVEF 
values did not affect the occurrence of AF in the 
study population. In a similar population of patients, 
Rivero-Ayerza et al. [14] also showed no differences 
in LVEF between patients with AF and patients 
without this arrhythmia. Straburzyńska-Migaj et al. 
[20] observed that in patients with systolic HF and 
SR, a considerably impaired LV diastolic function 
is independently associated with pulmonary hy-
pertension. LA enlargement and elevated tMxPG 
may therefore indirectly indicate an association 
between LV diastolic dysfunction with pAF in the 
course of CHF both in patients with preserved 
and in patients with impaired LV systolic function.
Conclusions
More advanced CHF was associated with pre-
sence of both types of AF. Non-ischemic etiology of 
HF and elevated CRP are independently associated 
with permanent AF compared to SR. LV diastolic 
dysfunction indicators (increased tMxPG and LA 
dimension) are independently associated with 
permanent AF.
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